Abdominal myomectomy surgery. Leiomyoma of uterus
Conditions
Interventions
Intervention 1: Intervention group: Intravenous infusion of oxytocin at a dose of 30 international units (IU) diluted in 500 ml of normal saline. Intervention 2: Control group: Intravenous infusion 50
Sponsors
Qazvin University of Medical Sciences
Eligibility
Sex/Gender
Female
Age
18 Years to 45 Years
Inclusion criteria
Inclusion criteria: Women aged 18 to 45 Diagnosis of symptomatic intramural uterine fibroids with a size greater than 5 cm and 1-3 in number Uterine size 14-16 weeks
Exclusion criteria
Exclusion criteria: Patients with known bleeding disorders People who are on anticoagulant therapy Patients with liver disease, cardiomyopathy, congestive heart failure, ischemic heart disease, hypertension, dyslipidemia, diabetes, recent vascular thrombosis, gynecological malignancy Previous treatment with Gonadotropin-releasing hormone Hemoglobin below 10 Lactating women Patients with a history of allergic reactions to oxytocin or other contraindications to its use Patients with a BMI greater than 35 kg/m2 Patients with multiple large myomas, which can significantly alter the standard abdominal myomectomy procedure.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Blood loss. Timepoint: Before and after surgery. Method of measurement: By measuring the number of gas and bottle suction during surgery and measuring hemoglobin levels using standard laboratory methods before and after surgery. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactFereshteh Odar
Qazvin University of Medical Sciences
Outcome results
None listed